SD 7 (DE005X) continuation 5-month data 3 mg/kg + MTX iv. SD 40 mg § sc./week for 12 weeks 80 mg § sc./week for 12 weeks 5.38–25.24 ng/ml [29] †Slightly decreased with increasing dose.

Yesterday, Amgen announced that it would launch the U.S.’s first marketed Humira-referenced biosimilar, Amjevita (adalimumab-atto), at two different list prices: $3,288 and $1,557 per 40 mg pen ...